Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are effective in improving liver inflammation in patients with MASLD
Most people regain some of the weight they lost after stopping semaglutide
MGB said it will continue to cover Wegovy, a rival GLP-1 from Novo Nordisk, and three other obesity drugs
Very large, hanging folds after massive weight loss usually require surgical removal, so non-surgical methods are best seen as a way to firm, lift and refresh skin rather than eliminate severe redundancy
(GSM is strongly linked to low oestrogen.) Infection risk : diabetes control, recent antibiotics, SGLT2 inhibitors, immunosuppression, sexual exposures
Clinical data from similar medications (Semaglutide and Tirzepatide) shows that participants regain approximately two-thirds of lost weight within 12 months of stopping treatment